stroke and brain injury, Completed Research

Safety, Efficacy and Tolerability of BAF312

August 17, 2023

< 1

Safety, Efficacy and Tolerability of BAF312 in Patients with Stroke due to Intracerebral Hemorrhage

A double blind, randomized, placebo-controlled phase II trial for Novartis (siponimod) in patients with intracerebral hemorrhage

Project Type: Research

Year started: 2021

Diagnosis: Stroke

Occupational and Physical Therapy Strategies for COVID-Related Guillain-Barré Syndrome: A Case...

Read details

Development and Validation of the SCI-Functional Index/Assistive Technology (SCI-FI/AT) Inpatient...

Read details

Clinical Comparison of Body-Weight Supported Standard and Balance-Perturbation Training Regimens...

Read details